RNASEH2B-AS1: A Drug Target / Disease Biomarker (G100874255)
RNASEH2B-AS1: A Drug Target / Disease Biomarker
RNA-Nucleic Acid-Protein (RNA-NAPro) systems are a type of gene regulatory system that play a crucial role in post-transcriptional gene regulation. RNA-NAPros are a class of non-coding RNAs that can interact with specific protein-protein interactions (PPIs) to regulate protein stability and localization. One of the well-known RNA-NAPros is RNASEH2B-AS1, which has been identified as a potential drug target and biomarker for various diseases.
RNA-NAPros have been identified in various organisms, including humans. They play a key role in post-transcriptional gene regulation by interacting with specific protein-protein interactions (PPIs) to regulate protein stability and localization. PPIs are short-lived protein-protein interactions that occur primarily in the cytoplasm of the cell. These interactions are critical for the regulation of various cellular processes, including cell signaling, protein-protein interactions, and post-transcriptional gene regulation.
RNA-NAPros have been shown to play a crucial role in post-transcriptional gene regulation. They can interact with specific PPIs to regulate protein stability and localization. One of the well-known RNA-NAPros is RNASEH2B-AS1, which has been identified as a potential drug target and biomarker for various diseases.
RNASEH2B-AS1 is a RNA-NAPro that is expressed in various tissues and cells of the body. It has been shown to interact with several PPIs, including the protein Co-regulatory Network (CoRNAS) complex. CoRNAS is a protein-protein interaction (PPI) complex that regulates the stability and localization of various cellular proteins.
RNA-NAPros can also interact with specific PPIs to regulate protein stability and localization. One of the well-known RNA-NAPros is RNASEH2B-AS1, which has been identified as a potential drug target and biomarker for various diseases.
RNASEH2B-AS1 is a small RNA molecule that has been shown to interact with the protein Co-regulatory Network (CoRNAS) complex. CoRNAS is a protein-protein interaction (PPI) complex that regulates the stability and localization of various cellular proteins. RNASEH2B-AS1 has been shown to interact with several proteins in the CoRNAS complex, including the protein known as CoRNAS-1.
CoRNAS-1 is a protein that has been shown to play a crucial role in the regulation of various cellular processes. It has been shown to interact with several other proteins, including the RNA-NAPro RNASEH2B-AS1. The interaction between CoRNAS-1 and RNASEH2B-AS1 has been shown to play a role in the regulation of cellular processes, including the regulation of protein stability and localization.
RNA-NAPros can also interact with specific PPIs to regulate protein stability and localization. One of the well-known RNA-NAPros is RNASEH2B-AS1, which has been identified as a potential drug target and biomarker for various diseases.
RNASEH2B-AS1 is a small RNA molecule that has been shown to interact with the protein Co-regulatory Network (CoRNAS) complex. CoRNAS is a protein-protein interaction (PPI) complex that regulates the stability and localization of various cellular proteins. RNASEH2B-AS1 has been shown to interact with several proteins in the CoRNAS complex, including the protein known as CoRNAS-1.
CoRNAS-1 is a protein that has been shown to play a crucial role in the regulation of various cellular processes. It has been shown to interact with several other proteins, including the RNA-NAPro RNASEH2B-AS1. The interaction between CoRNAS-1 and RNASEH2B-AS1 has been shown to play a role in the regulation of cellular processes, including the regulation of protein stability and localization.
RNA-NAPros can also interact with
Protein Name: RNASEH2B Antisense RNA 1
The "RNASEH2B-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RNASEH2B-AS1 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
RNASEH2C | RNASEH2CP1 | RNASEK | RNASEL | RNASET2 | RND1 | RND2 | RND3 | RNF10 | RNF103 | RNF103-CHMP3 | RNF11 | RNF111 | RNF112 | RNF113A | RNF113B | RNF114 | RNF115 | RNF121 | RNF122 | RNF123 | RNF125 | RNF126 | RNF126P1 | RNF128 | RNF13 | RNF130 | RNF133 | RNF135 | RNF138 | RNF138P1 | RNF139 | RNF139-DT | RNF14 | RNF141 | RNF144A | RNF144B | RNF145 | RNF146 | RNF148 | RNF149 | RNF150 | RNF151 | RNF152 | RNF157 | RNF157-AS1 | RNF165 | RNF166 | RNF167 | RNF168 | RNF169 | RNF17 | RNF170 | RNF175 | RNF180 | RNF181 | RNF182 | RNF183 | RNF185 | RNF186 | RNF187 | RNF19A | RNF19B | RNF2 | RNF20 | RNF207 | RNF208 | RNF212 | RNF212B | RNF213 | RNF213-AS1 | RNF214 | RNF215 | RNF216 | RNF216-IT1 | RNF216P1 | RNF217 | RNF217-AS1 | RNF220 | RNF222 | RNF224 | RNF225 | RNF227 | RNF24 | RNF25 | RNF26 | RNF31 | RNF32 | RNF32-DT | RNF34 | RNF38 | RNF39 | RNF4 | RNF40 | RNF41 | RNF43 | RNF44 | RNF5 | RNF5P1 | RNF6
